Life sciences company Ondine Biomedical announced the expansion of the availability of its Steriwave nasal photo disinfection technology on Friday across various hospitals in Canada.
Quebec-based hospitals pilot nasal photodisinfection to reduce antibiotic resistanceThe world-renowned Montreal Heart Institute and Hôpital Fleurimont, University of Sherbrooke (CHUS) in Sherbrooke, Quebec are piloting nasal photodisinfection to prevent post-operative infections in an era of rising antibiotic.
Ondine Biomedical presents research demonstrating high efficacy against Extensively Drug-Resistant (XDR) bacteria at ICPIC 2023Canadian life sciences company Ondine Biomedical Inc. (LON: OBI) has presented new research at the 2023 International Consortium on Prevention & Infection Control (ICPIC) in Geneva, demo.
Ondine Biomedical has presented new research at the 2023 International Consortium on Prevention & Infection Control (ICPIC) in Geneva. The data demonstrated.